.jpg "Nagendra V. Chemuturi, GDMPK photo")
Scientific Director Research
Takeda
Cambridge, Massachusetts
Nagendra Chemuturi received his Bachelor Degree in Pharmacy, with Distinction, from Kakatiya University in India. He then worked as a pharmaceutical sales representative before pursuing his Ph.D. at the University of Iowa. He was awarded the AAPS Graduate Symposium Award in 2005 for his dissertation work on the role of nasal drug transporters and metabolism in preferential nose-to-brain uptake of dopamine into brain. He started his career in the US at Vertex Pharmaceuticals in MA in 2005. Since then, he has worked at Alcon-Novartis and Seattle Genetics, and is currently with Takeda Pharmaceuticals. His experience lies in the fields of oncology and ophthalmology having served as DMPK lead on several small and large molecule projects. He is currently working on viral gene therapies including clinical aspects of viral gene therapies. He has given podium presentations at several scientific conferences, is active in IQ consortium, co-leading the MABEL working group, and has co-authored several articles and book chapters.
Disclosure information not submitted.
Tuesday, October 18, 2022
9:00 AM – 11:00 AM ET
Wednesday, October 19, 2022
3:45 PM – 4:00 PM ET